GlaxoSmithKline has topped the league table of pharma companies that contribute most to improving access to drugs in developing countries.
The Access to Medicine Index 2014 has placed GSK in first place for a fourth consecutive year, pipping Novo Nordisk to the post in second place. Put together by Access to Medicine Foundation, the approach has been developed with input from academics, NGOs, investors and governments, and pharma companies that this year have been more…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
